UnitedHealth Group Incorporated (NYSE:UNH) Stake Reduced by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,530 shares of the healthcare conglomerate’s stock after selling 12,170 shares during the quarter. UnitedHealth Group accounts for approximately 3.1% of Rhenman & Partners Asset Management AB’s investment portfolio, making the stock its 6th largest holding. Rhenman & Partners Asset Management AB’s holdings in UnitedHealth Group were worth $30,620,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $32,000. Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $40,000. Finally, Legacy Investment Solutions LLC purchased a new position in UnitedHealth Group in the third quarter worth $57,000. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Down 2.9 %

UNH stock opened at $524.94 on Friday. The firm has a market cap of $480.17 billion, a P/E ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s 50-day simple moving average is $509.24 and its 200-day simple moving average is $542.37.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.